About: Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.
Sector: Healthcare
Industry: Medical Devices
Latest price: A$10.73 (-1.29%)
AVR ASX Anteris Technologies Global Corp
Anteris Technologies Global Corp share price
AVR price activity
Último preço
$ 10,730
Variação (24h)
-0,14 AUD (-1,29%)
Volume
2.73K
Volume (média 4 sem.)
-
Abertura
$ 10,80
Variação do dia
$ 10,63 - $ 10,80
Fechamento anterior
$ 10,87
Último negócio
06 Oct, 4:25 am GMT+0
Atrasado
06 Oct, 4:25 am GMT+0
AVR price performance
Atrasado
06 Oct, 4:25 am GMT+0
quote.marketSignals